Found: 11
Select item for more details and to access through your institution.
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 11, p. 1842, doi. 10.3390/jpm12111842
- By:
- Publication type:
- Article
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2798, doi. 10.3390/cancers16162798
- By:
- Publication type:
- Article
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1144, doi. 10.3390/cancers16061144
- By:
- Publication type:
- Article
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 3030, doi. 10.3390/cancers15113030
- By:
- Publication type:
- Article
A Subset of PD-1-Expressing CD56 bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 329, doi. 10.3390/cancers15020329
- By:
- Publication type:
- Article
From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2974, doi. 10.3390/cancers12102974
- By:
- Publication type:
- Article
Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1525, doi. 10.3390/cells9061525
- By:
- Publication type:
- Article
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis.
- Published in:
- Drugs & Aging, 2021, v. 38, n. 3, p. 219, doi. 10.1007/s40266-021-00834-w
- By:
- Publication type:
- Article
Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer.
- Published in:
- Chemotherapy (0009-3157), 2010, v. 56, n. 2, p. 142, doi. 10.1159/000313527
- By:
- Publication type:
- Article
Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.568939
- By:
- Publication type:
- Article